La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Ontario1445
P. Seeman22
Ontario Sauf P. Seeman" 1430
P. Seeman Sauf Ontario" 7
Ontario Et P. Seeman 15
Ontario Ou P. Seeman 1452
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
003571 P. Seeman [Canada] ; D. Nam [Canada] ; C. Ulpian [Canada] ; I. S. C. Liu [Canada] ; T. Tallerico [Canada]New dopamine receptor, D2Longer, with unique TG splice site, in human brain
003861 P. Seeman [Canada] ; R. Corbett ; H H Van TolDopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
003868 P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
003869 P. Seeman [Canada] ; B K MadrasAnti-hyperactivity medication: methylphenidate and amphetamine.
003C92 P. Seeman [Canada] ; R. Corbett ; D. Nam ; H H Van TolDopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism.
003D00 T V Beischlag [Canada] ; D. Nam ; C. Ulpian ; P. Seeman ; H B NiznikA polymorphic dinucleotide repeat in the human dopamine D5 receptor gene promoter.
003F10 P. Seeman [Canada]Therapeutic receptor-blocking concentrations of neuroleptics.
004315 P. Seeman [Canada] ; H H Van TolDopamine receptor pharmacology.
004492 G. Mengod [Suisse] ; M. T. Villar [Suisse] ; G. B. Landwehrmeyer [Suisse] ; M. I. Martinez-Mir [Suisse] ; H. B. Niznik [Canada] ; R. K. Sunahara [Canada] ; P. Seeman [Canada] ; B. F. O'Dowd [Canada] ; A. Probst [Suisse] ; J. M. Palacios [Suisse]Visualization of dopamine D1, D2 and D3 receptor mRNA's in human and rat brain
004691 G. Mengod [Suisse] ; M. T. Vilar [Suisse] ; H. B. Niznik [Canada] ; R. K. Sunahara [Canada] ; P. Seeman [Canada] ; B. F. O'Dowd [Canada] ; J. M. Palacios [Suisse]Visualization of a dopamine D1 receptor mRNA in human and rat brain
004855 P. Seeman [Canada] ; H B NiznikDopamine receptors and transporters in Parkinson's disease and schizophrenia.
004C72 M. El-Awar [Canada] ; M. Freedman ; P. Seeman ; L. Goldenberg ; J. Little ; P. SolomonResponse of tardive and L-dopa-induced dyskinesias to antidepressants.
004C77 P. Seeman [Canada] ; N H Bzowej ; H C Guan ; C. Bergeron ; G P Reynolds ; E D Bird ; P. Riederer ; K. Jellinger ; W W TourtellotteHuman brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
004F17 M. Guttman [Canada] ; P. Seeman [Canada]L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum
005447 S. Roth [Canada] ; P. Seeman [Canada]Anesthetics expand erythrocyte membranes without causing loss of K+

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022